Oak Street Health, Inc. Peer Comparison
Metric | Value | Ranking | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $9.5 Billion | 2/15 | EHC $9.9B |
OSH $9.5B |
ENSG $7.2B |
ACHC $3.8B |
AMED $3.0B |
LFST $3.0B |
SEM $2.4B |
ADUS $2.1B |
AMEH $1.8B |
AGL $1.5B |
BKD $982.1M |
PNTG $890.7M |
INNV $457.1M |
CYH $453.0M |
MODV $78.5M |
Gross Margin | 100% | 1/15 | OSH 100% |
PNTG 100% |
MODV 100% |
AGL 100% |
ACHC 96% |
BKD 93% |
AMED 77% |
EHC 46% |
ADUS 33% |
CYH 21% |
AMEH 21% |
INNV 17% |
ENSG 15% |
SEM 11% |
LFST -48% |
Profit Margin | -6% | 12/15 | EHC 9% |
ACHC 8% |
AMED 7% |
ADUS 7% |
ENSG 7% |
AMEH 6% |
SEM 3% |
PNTG 3% |
INNV -2% |
LFST -2% |
MODV -4% |
OSH -6% |
BKD -6% |
AGL -8% |
CYH -13% |
EBITDA margin | 11% | 6/15 | LFST 177% |
SEM 88% |
ACHC 20% |
EHC 19% |
AMEH 12% |
OSH 11% |
ENSG 11% |
ADUS 10% |
BKD 5% |
AMED 4% |
PNTG 3% |
MODV 3% |
INNV 1% |
CYH -4% |
AGL -8% |
Quarterly Revenue | $752.0 Million | 8/15 | CYH $3.1B |
SEM $1.8B |
AGL $1.5B |
EHC $1.4B |
ENSG $1.1B |
ACHC $815.6M |
BKD $784.2M |
OSH $752.0M |
MODV $702.0M |
AMED $587.7M |
AMEH $348.2M |
LFST $312.7M |
ADUS $289.8M |
INNV $205.1M |
PNTG $180.7M |
Quarterly Earnings | -$48.2 Million | 12/15 | EHC $120.9M |
ENSG $78.4M |
ACHC $68.1M |
SEM $55.6M |
AMED $41.5M |
AMEH $22.1M |
ADUS $20.2M |
PNTG $6.2M |
INNV -$4.9M |
LFST -$6.0M |
MODV -$26.6M |
OSH -$48.2M |
BKD -$50.7M |
AGL -$117.6M |
CYH -$391.0M |
Quarterly Free Cash Flow | -$109.7 Million | 14/15 | SEM $289.0M |
BKD $162.2M |
AMED $104.2M |
ENSG $89.0M |
ADUS $46.6M |
PNTG $18.2M |
LFST $17.7M |
AMEH $11.3M |
AGL $6.7M |
MODV $2.4M |
CYH -$3.0M |
INNV -$9.7M |
ACHC -$27.1M |
OSH -$109.7M |
EHC -$0 |
Trailing 4 Quarters Revenue | $2.4 Billion | 9/15 | CYH $12.6B |
SEM $7.0B |
AGL $5.6B |
EHC $5.4B |
ENSG $4.1B |
ACHC $3.1B |
BKD $3.1B |
MODV $2.8B |
OSH $2.4B |
AMED $2.3B |
AMEH $1.3B |
LFST $1.2B |
ADUS $1.1B |
INNV $786.5M |
PNTG $652.3M |
Trailing 4 Quarters Earnings | -$462.9 Million | 15/15 | CYH $3.1B |
SEM $1.8B |
AGL $1.5B |
EHC $1.4B |
ENSG $1.1B |
ACHC $815.6M |
BKD $784.2M |
OSH $752.0M |
MODV $702.0M |
AMED $587.7M |
AMEH $348.2M |
LFST $312.7M |
ADUS $289.8M |
INNV $205.1M |
PNTG $180.7M |
Quarterly Earnings Growth | 50% | 5/15 | ACHC 131% |
LFST 90% |
AMED 60% |
INNV 52% |
OSH 50% |
PNTG 42% |
EHC 38% |
ADUS 31% |
ENSG 23% |
SEM 15% |
BKD -4% |
AMEH -15% |
AGL -274% |
CYH -330% |
MODV -518% |
Annual Earnings Growth | 10% | 9/15 | ACHC 34630% |
AMED 159% |
MODV 68% |
PNTG 66% |
INNV 64% |
LFST 52% |
EHC 33% |
ADUS 23% |
OSH 10% |
SEM -3% |
ENSG -6% |
AMEH -16% |
CYH -94% |
BKD -236% |
AGL -360% |
Quarterly Revenue Growth | 46% | 1/15 | OSH 46% |
PNTG 29% |
AGL 19% |
LFST 19% |
ENSG 15% |
EHC 13% |
INNV 12% |
AMEH 10% |
ACHC 9% |
ADUS 7% |
SEM 6% |
AMED 6% |
BKD 4% |
MODV 2% |
CYH 0% |
Annual Revenue Growth | 41% | 1/15 | OSH 41% |
PNTG 21% |
AGL 20% |
AMEH 18% |
LFST 16% |
EHC 10% |
ENSG 10% |
INNV 10% |
ADUS 8% |
ACHC 6% |
AMED 5% |
SEM 4% |
BKD 3% |
CYH 1% |
MODV 0% |
Cash On Hand | $136.8 Million | 7/15 | ENSG $532.1M |
BKD $254.7M |
AMED $245.5M |
ADUS $222.9M |
SEM $191.5M |
AGL $148.2M |
OSH $136.8M |
AMEH $103.2M |
LFST $102.6M |
EHC $85.4M |
ACHC $82.1M |
MODV $48.3M |
INNV $39.0M |
CYH $33.0M |
PNTG $4.5M |
Short Term Debt | $0 | 14/15 | SEM $292.6M |
MODV $241.8M |
BKD $203.5M |
EHC $164.9M |
CYH $133.0M |
ACHC $71.7M |
AMED $63.9M |
LFST $49.0M |
INNV $23.1M |
PNTG $19.1M |
ADUS $11.2M |
ENSG $4.1M |
AMEH $3.2M |
OSH -$0 |
AGL -$0 |
Long Term Debt | $1.4 Billion | 5/15 | CYH $12.0B |
BKD $5.0B |
SEM $4.3B |
ACHC $1.8B |
OSH $1.4B |
MODV $1.0B |
LFST $437.7M |
AMED $404.6M |
PNTG $357.8M |
EHC $189.7M |
ENSG $142.6M |
INNV $96.5M |
ADUS $38.6M |
AGL $34.9M |
AMEH $0 |
PE | -1.00 | 9/15 | PNTG 42.11 |
AMEH 36.37 |
ENSG 30.20 |
ADUS 28.13 |
AMED 23.80 |
EHC 21.67 |
ACHC 13.66 |
SEM 8.65 |
OSH -1.00 |
BKD -1.00 |
CYH -1.00 |
INNV -1.00 |
MODV -1.00 |
AGL -1.00 |
LFST -1.00 |
PS | 3.97 | 1/15 | OSH 3.97 |
LFST 2.49 |
EHC 1.84 |
ADUS 1.83 |
ENSG 1.78 |
AMEH 1.38 |
PNTG 1.37 |
AMED 1.31 |
ACHC 1.23 |
INNV 0.58 |
SEM 0.34 |
BKD 0.32 |
AGL 0.26 |
CYH 0.04 |
MODV 0.03 |
PB | 0.00 | 13/15 | PNTG 4.76 |
ENSG 4.14 |
EHC 3.47 |
BKD 3.34 |
AGL 2.56 |
AMED 2.53 |
ADUS 2.19 |
AMEH 2.17 |
LFST 2.09 |
INNV 1.57 |
ACHC 1.22 |
SEM 1.03 |
OSH 0.00 |
CYH 0.00 |
MODV 0.00 |
PC | 69.57 | 3/15 | PNTG 199.52 |
EHC 115.65 |
OSH 69.57 |
ACHC 46.68 |
LFST 29.31 |
AMEH 17.73 |
CYH 13.73 |
ENSG 13.62 |
AMED 12.37 |
SEM 12.33 |
INNV 11.72 |
AGL 9.93 |
ADUS 9.30 |
BKD 3.86 |
MODV 1.62 |
Liabilities to Equity | 0.00 | 12/15 | BKD 19.27 |
SEM 2.98 |
PNTG 2.71 |
AGL 2.64 |
ENSG 1.65 |
EHC 1.32 |
INNV 0.91 |
ACHC 0.90 |
AMED 0.82 |
LFST 0.47 |
ADUS 0.22 |
OSH 0.00 |
CYH 0.00 |
AMEH 0.00 |
MODV 0.00 |
ROA | -0.20 | 15/15 | EHC 7% | AMED 6% | ADUS 6% | AMEH 6% | ACHC 5% | ENSG 5% | SEM 3% | PNTG 3% | CYH -3% | INNV -3% | BKD -4% | LFST -5% | MODV -11% | AGL -18% | OSH -20% |
ROE | 1.74 | 2/15 | MODV 1077% |
OSH 174% |
CYH 31% |
EHC 16% |
SEM 14% |
ENSG 14% |
PNTG 12% |
AMED 11% |
ACHC 9% |
ADUS 8% |
INNV -6% |
LFST -7% |
AGL -65% |
BKD -71% |
AMEH -100% |
Current Ratio | 0.90 | 15/15 | AMEH 30.71 |
ADUS 5.62 |
LFST 3.14 |
AMED 2.28 |
INNV 2.23 |
ACHC 2.15 |
EHC 1.77 |
ENSG 1.61 |
PNTG 1.41 |
SEM 1.40 |
AGL 1.38 |
BKD 1.05 |
MODV 0.99 |
CYH 0.92 |
OSH 0.90 |
Quick Ratio | 0.14 | 8/15 | PNTG 42.11 |
AMEH 36.37 |
ENSG 30.20 |
ADUS 28.13 |
AMED 23.80 |
EHC 21.67 |
ACHC 13.66 |
SEM 8.65 |
OSH -1.00 |
BKD -1.00 |
CYH -1.00 |
INNV -1.00 |
MODV -1.00 |
AGL -1.00 |
LFST -1.00 |
Long Term Debt to Equity | -5.08 | 13/15 | BKD} 17.03 |
SEM} 2.23 |
PNTG} 2.11 |
ACHC} 0.60 |
INNV} 0.37 |
AMED} 0.35 |
LFST} 0.30 |
ENSG} 0.08 |
EHC} 0.07 |
AGL} 0.06 |
ADUS} 0.04 |
AMEH} -1.00 |
OSH} -5.08 |
CYH} -9.44 |
MODV} -60.04 |
Debt to Equity | -5.08 | 13/15 | BKD 17.03 |
SEM 2.38 |
PNTG 2.23 |
ACHC 0.62 |
INNV 0.42 |
AMED 0.41 |
LFST 0.34 |
EHC 0.13 |
ENSG 0.08 |
AGL 0.06 |
ADUS 0.05 |
AMEH -1.00 |
OSH -5.08 |
CYH -9.55 |
MODV -74.27 |
Burn Rate | 1.34 | 4/15 | ACHC 3.74 |
LFST 2.87 |
INNV 2.68 |
OSH 1.34 |
AGL 1.24 |
SEM 1.02 |
BKD 0.85 |
MODV 0.38 |
PNTG 0.35 |
CYH 0.04 |
EHC -1.18 |
AMEH -4.86 |
ENSG -7.42 |
ADUS -14.08 |
AMED -26.41 |
Cash to Cap | 0.01 | 13/15 | MODV 0.62 |
BKD 0.26 |
ADUS 0.11 |
AGL 0.10 |
INNV 0.09 |
SEM 0.08 |
AMED 0.08 |
CYH 0.07 |
ENSG 0.07 |
AMEH 0.06 |
LFST 0.03 |
ACHC 0.02 |
OSH 0.01 |
EHC 0.01 |
PNTG 0.01 |
CCR | 2.28 | 5/15 | SEM 5.20 |
PNTG 2.93 |
AMED 2.51 |
ADUS 2.31 |
OSH 2.28 |
INNV 1.97 |
ENSG 1.14 |
AMEH 0.51 |
CYH 0.01 |
AGL -0.06 |
MODV -0.09 |
ACHC -0.40 |
LFST -2.97 |
BKD -3.20 |
EHC |
EV to EBITDA | 125.12 | 5/15 | INNV} 392.03 |
PNTG} 205.05 |
BKD} 147.80 |
AMED} 125.37 |
OSH} 125.12 |
ADUS} 66.62 |
MODV} 60.39 |
ENSG} 56.16 |
AMEH} 39.93 |
EHC} 37.65 |
ACHC} 33.88 |
LFST} 6.12 |
SEM} 4.34 |
AGL} -12.08 |
CYH} -102.85 |
EV to Revenue | 4.47 | 1/15 | OSH 4.47 |
LFST 2.81 |
PNTG 1.94 |
EHC 1.89 |
BKD 1.84 |
ACHC 1.80 |
ENSG 1.68 |
ADUS 1.67 |
AMED 1.40 |
AMEH 1.31 |
CYH 1.00 |
SEM 0.97 |
INNV 0.67 |
MODV 0.46 |
AGL 0.24 |